Greg Lucier, chairman and CEO of Life Technologies, will join the board of directors of CareFusion, the public company to emerge from the planned spinoff of Cardinal Health's clinical and medical products businesses.
Joe DeRisi has received the 2009 American Society for Microbiology Eli Lilly and Company Research Award. He is a professor in the department of biochemistry and biophysics at the University of California, San Francisco, School of Medicine and a Howard Hughes Medical Investigator. He is honored for his work in advancing the basic technology and informatics for DNA microarrays and using these tools to investigate basic biological regulatory mechanisms. Currently, he works on the application of advanced genomic technologies to the study of human infectious diseases. DeRisi holds a PhD from Stanford University.
Peter Barrett, Robert Higgins, and Theo Melas-Kyriazi were elected at Helicos BioSciences' annual stockholder meeting last week to continue as company directors until the 2012 annual meeting of stockholders, or until their successors are elected and qualified.